» Articles » PMID: 40047129

COVID-19 Infection May Reduce Serum Testosterone Levels and Increase the Risk of Erectile Dysfunction: A Two-sample Mendelian Randomization Study

Overview
Specialty Urology
Date 2025 Mar 6
PMID 40047129
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Coronavirus disease 2019 (COVID-19) infection may affect serum hormones levels and male sexual function. This study aims to provide evidence for the causal relationship between COVID-19 infection, serum testosterone levels and the risk of erectile dysfunction (ED) using a two-sample Mendelian randomization (MR) approach.

Materials And Methods: Summary-level data for serum testosterone levels (199,569 samples and 12,321,875 single nucleotide polymorphisms [SNPs]) were obtained from Rebecca's study, while data for ED (6,175 cases and 217,630 controls) were sourced from Bovijn's study. Genetic variations linked to COVID-19 were used as instrumental variables (IVs) in meta-analyses of genome-wide association studies (GWASs) involving 6,406 cases and 902,088 controls from the COVID-19 Host Genetics Initiative. The inverse-variance weighted (IVW) method was primarily employed to evaluate the potential associations between COVID-19 infection, serum testosterone levels, and the risk of ED. The weighted mode, weighted-median and simple-median method were employed to evaluate the sensitivity. Heterogeneity and pleiotropic outlier were assessed using Cochran's Q test and MR-Egger regression.

Results: The MR analysis demonstrated that COVID-19 infection was associated with reduced serum testosterone levels (odds ratio [OR] 0.966, 95% confidence interval [CI] 0.938-0.993, p=0.016) and an increased risk of ED (OR 1.205, 95% CI 1.063-1.367, p=0.004) when using IVW methods. Sensitivity analyses utilizing various IV sets and MR approach remained consistent.

Conclusions: COVID-19 infection is associated with a decrease in serum testosterone levels and an increased risk of ED. Male patients recovering from COVID-19 need to pay special attention to their sex hormone levels and sexual health.

References
1.
Torzsok P, Oswald D, Steiner C, Abenhardt M, Ramesmayer C, Milinovic L . Effects of COVID-19 Infection on Spermatogenesis, Oxidative Stress and Erectile Function. J Clin Med. 2023; 12(22). PMC: 10672023. DOI: 10.3390/jcm12227099. View

2.
Cai Z, Zhong J, Jiang Y, Zhang J . Associations between COVID-19 infection and sex steroid hormones. Front Endocrinol (Lausanne). 2022; 13:940675. PMC: 9592769. DOI: 10.3389/fendo.2022.940675. View

3.
Yilmaz Baser H, Guzel A, Baser A . The impact of COVID-19 vaccination on the sexual health of male healthcare professionals. J Infect Dev Ctries. 2024; 17(12):1700-1705. DOI: 10.3855/jidc.18656. View

4.
Shamohammadi I, Kazemeyni S, Sadighi M, Hasanzadeh T, Dizavi A . Efficacy of tadalafil on improvement of men with erectile dysfunction caused by COVID-19: A randomized placebo-controlled trial. Asian J Urol. 2022; . PMC: 9374596. DOI: 10.1016/j.ajur.2022.05.006. View

5.
Unal S, Uzundal H, Soydas T, Kutluhan M, Ozayar A, Okulu E . A possible mechanism of erectile dysfunction in coronavirus disease-19: Cavernosal smooth muscle damage: A pilot study. Rev Int Androl. 2023; 21(4):100366. PMC: 10261716. DOI: 10.1016/j.androl.2023.100366. View